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Background
Natural rubber latex (NRL) sensitisation, often with seri-
ous symptoms of latex allergy, is a widespread problem of
patients with spina bifida. With genetic factors not being
well characterized till now, repeated surgeries beginning
soon after birth are the best-known risk factor. Operations
of the shunting devices mainly contribute to the number
of surgeries in spina bifida patients. There has been much
less investigation into the prevalence of NRL-sensitisation
of hydrocephalic patients without spina bifida.
Materials and methods
In this study the risk of NRL-sensitisation of hydro-
cephalic patients with and without spina bifida is com-
pared to give recommendations for NRL-prophylaxis. The
sera of a group of spina bifida patients without (n = 49) or
with shunted hydrocephalus (n = 123) and a group of 34
hydrocephalic patients without spina bifida were tested
for specific IgE antibodies against NRL by ImmunoCAP
system. The number of surgeries and symptoms of NRL




In all groups the prevalence of sensitisation against NRL
increased with the number of surgeries.
Conclusion
Due to repeated surgeries a remarkable sensitization
against NRL proteins in patients with shunted hydroceph-
alus without spina bifida has to be considered. The risk
increases with the number of surgeries like in spina bifida
patients and other congenital malformations. These
patients should be tested for specific IgE by blood or skin
test before surgeries, to establish prophylactic measures,
especially a latex-free operating theatre.
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Table 1: 
Group Patients n NRL sensitized NRL allergic Number of surgeries, mean/maximum
Spina bifida/No shunt 49 11/22.4%*1 4/8.2% n.s. 2.6/9*1
Spina bifida/with shunt 123 63/51% 17/13.8% 7.0/30
Shunt/No Spina bif. 34 6/17.7%*1 2/5.8% n.s. 5.7/12 n.s.
*1 Chi square test, p = 0.01, n.s. = not significant.
